Manopausal hormonal therapy and clinical and morphological features of endometrial cancer in women with metabolic disorders
- Authors: Klyukina L.A.1, Sosnova E.A.1, Ischenko A.A.2
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
- National Medical Research Center "Medical and Rehabilitation Center", Ministry of Health of Russia
- Issue: No 4 (2022)
- Pages: 141-147
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/274584
- DOI: https://doi.org/10.18565/aig.2022.4.141-147
- ID: 274584
Cite item
Abstract
Full Text
About the authors
Lidia A. Klyukina
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Email: hdiaklyukina@mail.ru
PhD student of the Department of Obstetrics and Gynecology No. 1, NV. Sklifosovsky Institute of Clinical Medicine
Elena A. Sosnova
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Email: sosnova-elena@inbox.ru
Dr. Med. Sci., Professor at the Department of Obstetrics and Gynecology No. 1, N.V. Sklifosovsky Institute of Clinical Medicine
Anton A. Ischenko
National Medical Research Center "Medical and Rehabilitation Center", Ministry of Health of Russia
Email: ra2001_2001@mail.ru
PhD, Head of the Center for Gynecology and New Reproductive Technologies
References
- Reeves G.K., Pirie K., Beral V., Green J., Spencer E., Bull D.; Million Women Study Collaboration. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007; 335(7630): 1134. https://dx.doi.org/10.1158/10.1136/bmj.39367.495995.AE.
- Silverberg S.G., Mutter G.L., Kurman R.J. Tumors of the uterine corpus: epithelial tumors and related lesions. In: Tavassoli F.A., Devilee P., eds. WHO Classification of tumors: pathology and genetics of tumors of the breast and female genital organs. Lyon, France: IARC Press; 2003.
- Бохман Я.В. Руководство по онкогинекологии. М.: Медицина; 1989. 325 с.
- Resnick K.E., Hampel H., Fishel R., Cohn D.E. Current and emerging trends in Lynch syndrome identification in women with endometrial cancer. Gynecol. Oncol. 2009; 114(1): 128-34. https://dx.doi.org/10.1016/j.ygyno.2009.03.003.
- Van den Bosch T., Coosemans A. Morina M., Timmerman D., Amant F. Screening for uterine tumours. Best Pract. Res. Clin. Obstet. Gynaecol. 2012; 26(2): 257-66. https://dx.doi.org/10.1016/j.bpobgyn.2011.08.002.
- Dinkelspiel H.E., Wright J.D., Lewin S.N., Herzog T.J. Contemporary clinical management of endometrial cancer. Obstet. Gynecol. Int. 2013; 2013: 583891. https://dx.doi.org/10.1155/2013/583891.
- Felix A.S., Brinton L.A. Cancer progress and priorities: uterine cancer. Cancer Epidemiol. Biomarkers Prev. 2018; 27(9): 985-94. https://dx.doi.org/10.1158/1055-9965.EPI-18-0264.
- Kiesel L., Eichbaum C., Baumeier A., Eichbaum M. Obesity epidemic - the underestimated risk of endometrial cancer. Cancers (Basel). 2020; 12(12): 3860. https://dx.doi.org/10.3390/cancers12123860.
- World Cancer Research Fund/American Institute for Cancer Research: Continuous update project report. Food: nutrition, physical activity, and the prevention of endometrial cancer. 2013. Available at: http://www.dietandcancerreport.org Accessed 1 November 2020.
- Bianchini F., Kaaks R., Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol. 2002; 3(9): 565-74. https://dx.doi.org/10.1016/s1470-2045(02)00849-5.
- Дедов И.И., Мокрышева Н.Г., Мельниченко Г.А., Трошина Е.А., Мазурина Н.В., Ершова Е.В., Комшилова К.А., Андреева Е.Н., Анциферов М.Б., Бирюкова Е.В., Бордан Н.С., Вагапова Г.Р., Волкова А.Р., Волкова Н.И., Волынкина А.П., Дзгоева Ф.Х., Киселева Т.П., Неймарк А.Е., Романцова Т.И., Руяткина Л.А., Суплотова Л.А., Халимов Ю.Ш., Яшков Ю.И. Ожирение. Клинические рекомендации. Consilium Medicum. 2021; 23(4): 311
- Лапина И.А., Гаврилов М.В., Таранов В.В., Доброхотова Ю.Э., Кольтинова Т.Г. Метаболический синдром как фактор риска сосудистых осложнений у больных раком эндометрия. Акушерство и гинекология. 2019; 6: 132-8. https://dx.doi.org/10.18565/aig.2019.6.132-138.
- Khandekar M.J., Cohen P., Spiegelman B.M. Molecular mechanisms of cancer development in obesity. Nat. Rev. Cancer. 2011; 11(12): 886-95. https://dx.doi.org/10.1038/nrc3174.
- Simpson E.R., Mahendroo M.S., Means G.D., Kilgore M.W., Hinshelwood M.M., Graham-Lorence S. et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr. Rev. 1994; 15(3): 342-55. https://dx.doi.org/10.1210/edrv-15-3-342.
- Rodriguez A.C., Blanchard Z., Maurer K.A., Gertz J. Estrogen signaling in endometrial cancer: A key oncogenic pathway with several open questions. Horm. Cancer. 2019; 10: 51-63. https://dx.doi.org/10.1007/s12672-019-0358-9.
- Hou X., Zhao M., Wang T., Zhang G. Upregulation of estrogen receptor mediates migration, invasion and proliferation of endometrial carcinoma cells by regulating the PI3K/AKT/mTOR pathway. Oncol. Rep. 2014; 31(3): 1175-82. https://dx.doi.org/10.3892/or.2013.2944.
- Yang B., Chen R., Liang X., Shi J., Wu X., Zhang Z., Chen X. Estrogen enhances endometrial cancer cells proliferation by upregulation of prohibitin. J. Cancer. 2019; 10(7): 1616-21. https://dx.doi.org/10.7150/jca.28218.
- Khandwala H.M., McCutcheon I.E., Fyvbjerg A., Friend K.E. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr. Rev. 2000; 21: 215-44. https://dx.doi.org/10.1210/edrv.2L3.0399.
- Tumminia A., Vinciguerra F., Parisi M., Graziano M., Sciacca L., Baratta R., Frittitta L. Adipose tissue, obesity and adiponectin: role in endocrine cancer risk. Int. J. Mol. Sci. 2019; 20(12): 2863. https://dx.doi.org/10.3390/ijms20122863.
- Кишкина А.Ю., Коломиец Л.А., Юнусова Н.В. Клинические варианты метаболического синдрома у больных раком эндометрия. Сибирский онкологический журнал. 2019; 18(5): 38-44. [Kishkina A.Yu., Kolomiets L.A., Yunusova N.V. Clinical options for metabolic syndrome in patients with endometrial cancer. Sibirskij onkologicheskij zhurnal/ Siberian Oncological Journal. 2019; 18(5): 38-44 (in Russian)]. https://dx.doi.org/10.21294/1814-4861-2019-18-5-38-44.
- Tawfik A., Bassma M., Elsabaa Dalia A., Sally S., El-Tawab, Heba A. The impact of metabolic syndrome on the clinical profile and tumor characteristics of endometrial carcinoma. J. Reprod. Contracept. Obstet. Gynecol. 2016; 5(11): 3696-703. https://dx.doi.org/10.18203/2320-1770.
- Razavi P., Pike M.C., Horn-Ross P.L., Templeman C., Bernstein L., Ursin G. Long-term postmenopausal hormone therapy and endometrial cancer. Cancer Epidemiol. Biomark. Prev. 2010; 19(2): 475-83. https://dx.doi.org/10.1158/1055-9965.EPI-09-0712.
- Sponholtz T.R., Palmer J.R., Rosenberg L.A., Hatch E.E., Adams-Campbell L.L., Wise L.A., Lucile A.-C. Exogenous hormone use and endometrial cancer in U.S. Black Women. Cancer Epidemiol. Biomark. Prev. 2018; 27(5): 558-65. https://dx.doi.org/10.1158/1055-9965.EPI-17-0722.
- Jaakkola S., Lyytinen H.K., Dyba T., Ylikorkala O., Pukkala E. Endometrial cancer associated with various forms of postmenopausal hormone therapy: A case control study. Int. J. Cancer. 2011; 128(7): 1644-51. https://dx.doi.org/10.1002/ijc.25762.
- Phipps A.I., Doherty J.A., Voigt L.F., Hill D.A., Beresford S.A.A., Rossing M.A. et al. Long-term use of continuous-combined estrogen-progestin hormone therapy and risk of endometrial cancer. Cancer Causes Control. 2011; 22(12): 1639-46. https://dx.doi.org/10.1007/s10552-011-9840-6.
- McCullough M.L., Patel A.V., Patel R., Rodriguez C., Feigelson H.S., Bandera E.V. et al. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. Cancer Epidemiol. Biomark. Prev. 2008; 17: 73-9. https://dx.doi.org/10.1158/1055-9965.EPI-07-2567.
- Simin J., Tamimi R., Lagergren J., Adami H.-O., Brusselaers N. Menopausal hormone therapy and cancer risk: An overestimated risk? Eur. J. Cancer. 2017; 84: 60-8. https://dx.doi.org/10.1016/j.ejca.2017.07.012.
- Nelson H.D., Humphrey L.L., Nygren P., Teutsch S.M., Allan J.D. Postmenopausal hormone replacement therapy: scientific review. JAMA. 2002; 288(7): 872e81. https://dx.doi.org/10.1001/jama.288.7.872.